Enanta Pharmaceuticals Share Holder Equity 2011-2025 | ENTA

Enanta Pharmaceuticals share holder equity from 2011 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
Enanta Pharmaceuticals Annual Share Holder Equity
(Millions of US $)
2024 $129
2023 $217
2022 $321
2021 $399
2020 $456
2019 $462
2018 $394
2017 $302
2016 $270
2015 $236
2014 $149
2013 $110
2012 $44
2011 $22
2010 $0
Enanta Pharmaceuticals Quarterly Share Holder Equity
(Millions of US $)
2024-12-31 $112
2024-09-30 $129
2024-06-30 $149
2024-03-31 $166
2023-12-31 $192
2023-09-30 $217
2023-06-30 $238
2023-03-31 $269
2022-12-31 $301
2022-09-30 $321
2022-06-30 $338
2022-03-31 $359
2021-12-31 $384
2021-09-30 $399
2021-06-30 $418
2021-03-31 $436
2020-12-31 $452
2020-09-30 $456
2020-06-30 $481
2020-03-31 $486
2019-12-31 $482
2019-09-30 $462
2019-06-30 $448
2019-03-31 $436
2018-12-31 $427
2018-09-30 $394
2018-06-30 $361
2018-03-31 $333
2017-12-31 $318
2017-09-30 $302
2017-06-30 $261
2017-03-31 $266
2016-12-31 $268
2016-09-30 $270
2016-06-30 $269
2016-03-31 $266
2015-12-31 $264
2015-09-30 $236
2015-06-30 $228
2015-03-31 $224
2014-12-31 $194
2014-09-30 $149
2014-06-30 $153
2014-03-31 $102
2013-12-31 $106
2013-09-30 $110
2013-06-30 $114
2013-03-31 $118
2012-12-31 $0
2012-09-30
2012-06-30 $0
2012-03-31 $0
2011-09-30 $22
2010-09-30 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.111B $0.068B
Enanta Pharmaceuticals, Inc. is a biotechnology company. It engages in the research and development of molecule drugs for the treatment of infectious diseases such as hepatitis C virus, respiratory tract infections, intravenous and oral treatments. Enanta Pharmaceuticals, Inc. is headquartered in Watertown, Massachusetts.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $82.901B 31.10
Zoetis (ZTS) United States $68.972B 25.73
Daiichi Sankyo, - (DSNKY) Japan $43.624B 22.19
Takeda Pharmaceutical (TAK) Japan $43.624B 8.68
Sandoz Group AG (SDZNY) Switzerland $19.765B 0.00
Merck (MKKGY) Germany $17.939B 14.85
Summit Therapeutics (SMMT) United States $16.896B 0.00
United Therapeutics (UTHR) United States $13.518B 11.96
Shionogi (SGIOY) Japan $12.590B 12.61
Neurocrine Biosciences (NBIX) United States $11.755B 40.26
IPSEN (IPSEY) France $9.548B 0.00
Orion OYJ (ORINY) Finland $8.544B 23.11
Corcept Therapeutics (CORT) United States $7.512B 61.07
Stevanato Group S.p.A (STVN) Italy $7.183B 43.93
Madrigal Pharmaceuticals (MDGL) United States $6.280B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Grifols, S.A (GRFS) Spain $5.205B 0.00
Ionis Pharmaceuticals (IONS) United States $5.189B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 10.32
Soleno Therapeutics (SLNO) United States $3.702B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.930B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.854B 10.00
Hypermarcas (HYPMY) Brazil $2.687B 17.67
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.278B 12.46
BioCryst Pharmaceuticals (BCRX) United States $2.061B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.059B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.752B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.639B 0.00
Guardian Pharmacy Services (GRDN) United States $1.527B 0.00
Indivior (INDV) United States $1.521B 6.45
Evotec AG (EVO) Germany $1.449B 0.00
Dyne Therapeutics (DYN) United States $1.330B 0.00
ARS Pharmaceuticals (SPRY) United States $1.188B 0.00
Ocular Therapeutix (OCUL) United States $1.104B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.061B 21.22
Enliven Therapeutics (ELVN) United States $0.976B 0.00
Collegium Pharmaceutical (COLL) United States $0.934B 5.04
Harrow (HROW) United States $0.922B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.824B 0.00
Cronos Group (CRON) Canada $0.794B 0.00
Ardelyx (ARDX) United States $0.785B 0.00
Xeris Biopharma Holdings (XERS) United States $0.726B 0.00
AleAnna (ANNA) United States $0.706B 0.00
Akebia Therapeutics (AKBA) United States $0.643B 0.00
Xencor (XNCR) United States $0.579B 0.00
KalVista Pharmaceuticals (KALV) United States $0.564B 0.00
USANA Health Sciences (USNA) United States $0.544B 11.83
Regulus Therapeutics (RGLS) United States $0.543B 0.00
CytoDyn (CYDY) United States $0.532B 0.00
Bioventus (BVS) United States $0.523B 13.29
Savara (SVRA) United States $0.517B 0.00
Relay Therapeutics (RLAY) United States $0.475B 0.00
Elite Pharmaceuticals (ELTP) United States $0.471B 0.00
Altimmune (ALT) United States $0.462B 0.00
Zevra Therapeutics (ZVRA) United States $0.445B 0.00
Siga Technologies (SIGA) United States $0.424B 8.85
Theravance Biopharma (TBPH) Cayman Islands $0.421B 0.00
Tourmaline Bio (TRML) United States $0.398B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.388B 0.00
Verve Therapeutics (VERV) United States $0.384B 0.00
Organogenesis (ORGO) United States $0.382B 0.00
Oruka Therapeutics (ORKA) United States $0.364B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.327B 8.83
Nature's Sunshine Products (NATR) United States $0.263B 24.29
Heron Therapeutics (HRTX) United States $0.262B 0.00
ProKidney (PROK) United States $0.226B 0.00
Aquestive Therapeutics (AQST) United States $0.221B 0.00
MediWound (MDWD) Israel $0.210B 0.00
OmniAb (OABI) United States $0.186B 0.00
Nanobiotix S.A (NBTX) France $0.183B 0.00
Avita Medical (RCEL) United States $0.177B 0.00
Liminatus Pharma (LIMN) $0.169B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.162B 0.00
Inhibikase Therapeutics (IKT) United States $0.158B 0.00
4D Molecular Therapeutics (FDMT) United States $0.145B 0.00
Esperion Therapeutics (ESPR) United States $0.145B 0.00
Journey Medical (DERM) United States $0.138B 0.00
Nektar Therapeutics (NKTR) United States $0.133B 0.00
Korro Bio (KRRO) United States $0.133B 0.00
Aldeyra Therapeutics (ALDX) United States $0.130B 0.00
Wellgistics Health (WGRX) United States $0.129B 0.00
Aclaris Therapeutics (ACRS) United States $0.128B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Profound Medical (PROF) Canada $0.121B 0.00
Protara Therapeutics (TARA) United States $0.121B 0.00
Lyell Immunopharma (LYEL) United States $0.115B 0.00
Larimar Therapeutics (LRMR) United States $0.115B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.105B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.092B 0.00
VAXART, INC (VXRT) United States $0.091B 0.00
Cassava Sciences (SAVA) United States $0.091B 0.00
Champions Oncology (CSBR) United States $0.089B 14.70
Lexeo Therapeutics (LXEO) United States $0.089B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.086B 0.00
Achieve Life Sciences (ACHV) Canada $0.086B 0.00
Dominari Holdings (DOMH) United States $0.085B 0.00
Galectin Therapeutics (GALT) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Telomir Pharmaceuticals (TELO) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Fractyl Health (GUTS) United States $0.075B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.074B 55.11
Context Therapeutics (CNTX) United States $0.071B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Unicycive Therapeutics (UNCY) United States $0.067B 0.00
Pyxis Oncology (PYXS) United States $0.066B 0.00
Nutriband (NTRB) United States $0.063B 0.00
Vivani Medical (VANI) United States $0.060B 0.00
Assertio Holdings (ASRT) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Metagenomi (MGX) United States $0.056B 0.00
Gain Therapeutics (GANX) United States $0.055B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.050B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
PMV Pharmaceuticals (PMVP) United States $0.044B 0.00
Century Therapeutics (IPSC) United States $0.042B 0.00
Karyopharm Therapeutics (KPTI) United States $0.042B 0.00
Prelude Therapeutics (PRLD) United States $0.039B 0.00
NRx Pharmaceuticals (NRXP) United States $0.039B 0.00
Avalo Therapeutics (AVTX) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
FibroGen (FGEN) United States $0.030B 0.00
PolyPid (PYPD) Israel $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Mannatech (MTEX) United States $0.022B 0.00
Surrozen (SRZN) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Jupiter Neurosciences (JUNS) United States $0.020B 0.00
DURECT (DRRX) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
GlycoMimetics (GLYC) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
MEI Pharma (MEIP) United States $0.015B 0.00
Relmada Therapeutics (RLMD) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.011B 1.88
Talphera (TLPH) United States $0.010B 0.00
BioLineRx (BLRX) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Klotho Neurosciences (KLTO) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Incannex Healthcare (IXHL) Australia $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00